1 completed, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Fallopian Tube Serous Neoplasm: new trials by email Literature Review of Fallopian Tube Serous Neoplasm trials Research Report on Fallopian Tube Serous Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer Hsp90 Inhibitor AT13387, Laboratory Biomarker Analysis, Pharmacological Study - Adult Solid Neoplasm, Estrogen Receptor Negative | Phase 1 | Withdrawn | National Cancer Institute (NCI) | 2016-03-01 | 2016-07-26 | |
| Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Bevacizumab, Carboplatin, Cisplatin - Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma | Phase 1 | Completed | National Cancer Institute (NCI) | 431 | 2009-10-28 | 2021-10-20 |
Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2) · Breast Neoplasms (1) · Brenner Tumor (1) · Triple Negative Breast Neoplasms (1)
Adnexal Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Fallopian Tube Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Neoplasms (2) · Neoplasms by Site (2) · Ovarian Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
(2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone (1) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Bevacizumab (1) · Carboplatin (1) · Cisplatin (1) · Disulfides (1) · Immunoglobulin G (1) · Paclitaxel (1) · Platinum (1) · Taxes (1) · talazoparib (1) · veliparib (1)
National Cancer Institute (NCI) (2)
United States (1)
Katherine M Bell-McGuinn (1) · Panagiotis Konstantinopoulos (1)
P30CA006516 (1), U10CA027469 (1), U10CA180868 (1), UM1CA186709 (1)